The reimbursement process works like this: App store subscriptions (Apple or Google Play) get billed through those platforms according to their terms, so check their policies if you go that route
A 2024 study presented at the American Association of Clinical Endocrinology meeting showed that combining androgen receptor modulators with GLP-1 therapy increased lean mass while simultaneously decreasing fat mass
Also it's worth noting that if you have blood work conducted and it returns as falling within "the normal range" then know that "normal" does not equal optimal and therefore, if you do suffer any of the symptoms noted above with "normal levels" then you may well benefit from the extra boost
While compounded GLP-1 medications are not FDA-approved, they are prepared in facilities that follow FDA and state pharmacy regulations
Finally, the FLOW trial may shed further light on the potential mechanisms involved on how GLP-1 receptor agonism could alter renal physiology, combined with future mechanistic studies that aim to find proof for the effects of GLP-1 receptor agonists on the renal risk factors/pathophysiological mechanisms related to DKD as summarized in this review